Nitrites

Living reference work entry

Abstract

Nitrites have been used in a variety of food packaging, manufacturing, and medical settings for more than 150 years. The therapeutic benefit of nitrites was first investigated in the mid-1800s, when nitroglycerin was used as a treatment for angina [1]. Antidotal use of nitrites currently is reserved as a secondary treatment for cyanide poisoning and for consideration in the treatment of severe hydrogen sulfide poisoning. There are no human studies that are available to demonstrate benefits of nitrites in hydrogen sulfide overdoses. Animal studies of nitrites for hydrogen sulfide are equivocal. In the USA, two nitrite agents were packaged together in the cyanide antidote kit (originally manufactured by Eli Lilly and Company); the current cyanide antidote kit contains sodium nitrite (NaNO2) injection and sodium thiosulfate injection (Nithiodote®, Hope Pharmaceuticals, Scottsdale, AZ). These agents have been used for the treatment of cyanide toxicity since the 1930s. However, since its approval by the US Food and Drug Administration in 2006, hydroxocobalamin is considered the preferred cyanide antidote in the USA, Europe, and Australia [2].

Keywords

Hydrogen Sulfide Sodium Nitrite Secondary Treatment Cyanide Poisoning Cyanide Toxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Murrell W. Lancet. 1879;1:80–1. 113–115, 151–152, 225–227.CrossRefGoogle Scholar
  2. 2.
    Reade MC, Davies SR, Morley PT, Dennett J, Jacobs IC. Review article: management of cyanide poisoning. Emerg Med Australas. 2012;24(3):225–38.CrossRefPubMedGoogle Scholar
  3. 3.
    Wood GB, Bache F. Nitrite of amyl. In United States dispensatory, vol 15. Philadelphia: JB Lippincott; 1883. pp 185–6.Google Scholar
  4. 4.
    Pedigo LG. Antagonism between amyl nitrite and prussic acid. Tr Med Soc Virginia. 1888;19:124–31.Google Scholar
  5. 5.
    Mladoveanu C, Gheorhiu P. Le nitre de sou de comme antidote de l’empoisonnement experimental pa le cyanure de potassium. Compt Rend Soc Biol. 1929;102:164–6.Google Scholar
  6. 6.
    Geiger JC. Cyanide poisoning in San Francisco. JAMA. 1932;99:1944–5.CrossRefGoogle Scholar
  7. 7.
    Mota MM. Sobre un caso de intoxicación por cianuro de potasio tratado con exito por el nitrito de sodio. Rev Med Rossario. 1933;23:670–4.Google Scholar
  8. 8.
    Chen KK, Rose CL, Clowes GH. Methylene blue, nitrites, and sodium thiosulfate against cyanide poisoning. Proc Soc Exp Biol Med. 1933;31:250–2.CrossRefGoogle Scholar
  9. 9.
    Chen KK, Rose CL, Clowes GH. Amyl nitrite and cyanide poisoning. JAMA. 1933;100:1920–2.CrossRefGoogle Scholar
  10. 10.
    Baselt RC. Disposition of toxic drugs and chemicals in man. 5th ed. Foster City: Chemical Toxicology Institute; 2000.Google Scholar
  11. 11.
    Toll LL, Hurlbut KM, editors. Nitrites. In Klasco RK, editor. POISINDEX system. Thompson MICROMEDEX, Greenwood Village, CO. Edition expires 6/2004.Google Scholar
  12. 12.
    Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitrite and nitrate determinations in plasma. Clin Chem. 1995;41:892–6.PubMedGoogle Scholar
  13. 13.
    Rath MM, Kratz JC. Nitrites: IX. A further study of the mechanism of the action of organic nitrates. J Pharm Exp Ther. 1942;76:33–8.Google Scholar
  14. 14.
    Way JL. Cyanide intoxication and its mechanism of antagonism. Ann Rev Pharmacol Toxicol. 1984;24:451–8.CrossRefGoogle Scholar
  15. 15.
    Hall AH, Rumack BH, Shaffer MO, et al. Clinical toxicology of cyanide: North American clinical experiences. In: Ballantyne B, Marrs TC, editors. Clinical and experimental toxicology of cyanides. Bristol: John Wright and Sons; 1987. p. 312.Google Scholar
  16. 16.
    Hall AH, Doutre WH, Ludden T, et al. Nitrite/thiosulfate treated acute cyanide poisoning: estimated kinetics after antidote. Clin Toxicol. 1987;25:121–33.Google Scholar
  17. 17.
    Johnson WS, Hall AH, Rumack BH. Cyanide poisoning successfully treated without “therapeutic methemoglobin levels”. Ann Emerg Med. 1989;7:437–40.Google Scholar
  18. 18.
    Way JL, Sylvester D, Morgan RL, et al. Recent perspectives on the toxicodynamic basis of cyanide antagonism. Fundam Appl Toxicol. 1984;4:S231–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Torres J, Darley-Usmar V, Wilson MT. Inhibition of cytochrome oxidase in turnover by nitric oxide: mechanism and implications for control of respiration. Biochem J. 1995;312(Pt1):169–73.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Leavesley HB, Li L, Prabhakaran K, Borowitz JL, Isom GE. Interaction of cyanide and nitric oxide with cytochrome c oxidase: implications for acute cyanide toxicity. Toxicol Sci. 2008;101:101–11.CrossRefPubMedGoogle Scholar
  21. 21.
    Wurzburg H. Treatment of cyanide poisoning in an industrialized setting. Vet Hum Toxicol. 1996;38:44–7.PubMedGoogle Scholar
  22. 22.
    Graham DL, Laman D, Theodore J, et al. Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Intern Med. 1977;137:1051–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Yen D, Tsai J, Wang LM, et al. The clinical experience of acute cyanide poisoning. Am J Emerg Med. 1995;13:524–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Hall AH, Rumack BH. Clinical toxicology of cyanide. Ann Emerg Med. 1986;15:1067–74.CrossRefPubMedGoogle Scholar
  25. 25.
    Berlin CM. Treatment of cyanide poisoning in children. Pediatrics. 1970;46:793–6.PubMedGoogle Scholar
  26. 26.
    Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th ed. Baltimore: Williams & Wilkins; 1994.Google Scholar
  27. 27.
    Kulig K. Cyanide antidotes and fire toxicology. N Engl J Med. 1991;325:1801–2.CrossRefPubMedGoogle Scholar
  28. 28.
    Holland MA, Kozloski LM. Clinical features and management of cyanide poisoning. Clin Pharm. 1986;5:737–41.PubMedGoogle Scholar
  29. 29.
    Marrs TC. Antidotal treatment of acute cyanide poisoning. Adv Drug React Acute Poisoning Rev. 1988;4:179–206.Google Scholar

Copyright information

© Springer International Publishing AG 2016

Authors and Affiliations

  1. 1.School of PharmacyUniversity of Maryland-BaltimoreBaltimoreUSA

Personalised recommendations